Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Luke J Jacobi

114 posts
Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • News

Twist Bioscience Incorporates MOLCURE AI Technology to Augment Therapeutic Antibody Discovery

By Luke J Jacobi
Today, 5:42 AM
Twist Bioscience Corporation (NASDAQ:TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and MOLCURE Inc., today announced they generated potent,

TWST

Read More
2 minute read
  • News

F-star Therapeutics Says Early Data From SB 11285 ‘Encourage Further Dose Escalation’

By Luke J Jacobi
Today, 5:42 AM
F-star Therapeutics, Inc. (NASDAQ:FSTX) ("F-star" or the "Company"), a clinical-stage biopharmaceutical company dedicated to developing next generation immunotherapies to transform the lives of

FSTX

Read More
1 minute read
  • Earnings
  • News

Lennox International Q2 EPS $4.57 Beats $4.26 Estimate, Sales $1.24B Beat $1.15B Estimate

By Luke J Jacobi
Today, 5:42 AM
Lennox International (NYSE:LII) reported quarterly earnings of $4.57 per share which beat the analyst consensus estimate of $4.26 by 7.28 percent. This is a 53.87 percent increase over earnings of $2.97 per share from

LII

Read More
1 minute read
  • Earnings
  • News

Lockheed Martin Q1 EPS $6.56 Beats $6.30 Estimate, Sales $16.26B Miss $16.33B Estimate

By Luke J Jacobi
Today, 5:42 AM
Lockheed Martin (NYSE:LMT) reported quarterly earnings of $6.56 per share which beat the analyst consensus estimate of $6.30 by 4.13 percent. This is a 7.89 percent increase over earnings of $6.08 per share from the same

LMT

Read More
1 minute read
  • Earnings
  • News

Alliance Resource Q2 EPS $0.53 Beats $0.21 Estimate, Sales $362.44M Miss $372.70M Estimate

By Luke J Jacobi
Today, 5:42 AM
Alliance Resource (NASDAQ:ARLP) reported quarterly earnings of $0.53 per share which beat the analyst consensus estimate of $0.21 by 152.38 percent. This is a 243.24 percent increase over losses of $(0.37) per share from

ARLP

Read More
1 minute read
  • Earnings
  • News

Dorman Products Q2 EPS $1.10 Beats $1.03 Estimate, Sales $310.60M Beat $287.87M Estimate

By Luke J Jacobi
Today, 5:42 AM
Dorman Products (NASDAQ:DORM) reported quarterly earnings of $1.10 per share which beat the analyst consensus estimate of $1.03 by 6.8 percent. This is a 134.04 percent increase over earnings of $0.47 per share from the

DORM

Read More
2 minute read
  • FDA
  • News

Iterum Therapeutics Receives Complete Response Letter from Food and Drug Administration for Oral Sulopenem, FDA Requests At Least 1 Additional Trial

By Luke J Jacobi
Today, 5:42 AM
Iterum Therapeutics plc (NASDAQ:ITRM) (the "Company"), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant

ITRM

Read More
2 minute read
  • News

First High-School Education Makes Statement About New Regulations From the Chinese Government Regarding New Regulation: ‘The Company’s Existing Business is Expected to Operate in a Normal Fashion”

By Luke J Jacobi
Today, 5:42 AM
First High-School Education Group Co., Ltd. ("First High-School Education Group" or the "Company") (NYSE:FHS), the largest operator of private high schools in Western China and third largest

FHS

Read More
2 minute read
  • News

Zhangmen Education Says the Chinese Government’s Policy on For-Profit Education ‘to Have Material Impacts on Our Existing Business Operations, Financial Condition and Corporate Structure’

By Luke J Jacobi
Today, 5:42 AM
Zhangmen Education Inc. ("Zhangmen" or the "Company") (NYSE:ZME), a leading online education company in China focused on providing personalized online courses to K-12 students, noted that

ZME

Read More
1 minute read
  • Guidance
  • News

Tractor Supply Raises FY2021 GAAP EPS Guidance from $7.05-7.40 to $7.70-8.00 vs $7.38 Est; Raises FY2021 Sales Guidance from $11.40B-11.70B to $12.10B-12.30B vs $11.64B Est

By Luke J Jacobi
Today, 5:42 AM
Tractor Supply (NASDAQ:TSCO) raises FY2021 GAAP EPS guidance from $7.05-7.40 to $7.70-8.00 vs $7.38 analyst estimate. Raises FY2021 sales outlook from $11.40 billion-11.70 billion to $12.10 billion-12.30 billion vs

TSCO

Posts navigation

Previous 1 … 8 9 10 … 12 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service